E-DRUG: New Dutch Foundation to take on high medicines prices
-------------------------------------------------------------------------------
Dear e-drug readers,
Here is my latest blog about a new Dutch Foundation that plans to take on high drug prices and details about its first case: an old medicine which has obtained an orphan drug indication and returned to the market with a price 500 times higher than the older product.
E-DRUG: New Dutch Foundation to take on high medicines prices (2)
---------------------------------------------------------------------------------
Dear Ellen,
This is exciting news and an important case. If the Foundation and its advisors would like an example of details about the structure of manufacturing costs, they could look at the appendices of the research we did for the Access Campaign by MSF/Doctors Without Borders on fixed, semi-fixed, annual, and variable costs.
The article was published by VACCINE, and thanks to MSF, it is free: